Persistent dyskinesia.
D000367:Age Factors; D001925:Brain Damage, Chronic / Q000150:complications; D002493:Central Nervous System Diseases / Q000150:complications; D004298:Dopamine / Q000502:physiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D009069:Movement Disorders / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy; D010640:Phenothiazines / Q000009:adverse effects; D012110:Reserpine / Q000627:therapeutic use; D012559:Schizophrenia / Q000150:complications; D012737:Sex Factors; D014149:Tranquilizing Agents / Q000009:adverse effects
D008996:Monoamine Oxidase Inhibitors; D010640:Phenothiazines; D014149:Tranquilizing Agents; D012110:Reserpine; D004298:Dopamine